Accuri Cytometers Secures $13 million

Accuri Cytometers secured $13 million in Series C financing from fundraising leaders and new investors Fidelity Biosciences and Flagship Ventures, as well as investors Arboretum Ventures and Baird Venture Partners. The life sciences business is based in Ann Arbor, Mich.